High-performance liquid chromatographic assay for the determination of the novel podophyllotoxin derivative dimethylaminoetoposide (NK611) in human plasma

J Chromatogr B Biomed Appl. 1994 Mar 18;654(1):97-102. doi: 10.1016/0378-4347(93)e0453-w.

Abstract

A simple, rapid and reproducible plasma assay for the determination of the novel epipodophyllotoxin derivative, dimethylaminoetoposide (NK611, I) and its N-demethyl metabolite (II) is reported. The method involves solid-phase extraction using an isolute C18 cartridge and HPLC separation on a reduced-activity C18 column (8 cm long) with a mobile phase of acetonitrile-water-0.1 M phosphoric acid (23:76:1, v/v/v); peaks are detected at 205 nm. The intra- and inter-day precision and accuracy are within 5 and 4% for I and II, respectively. The sensitivity is 20 ng/ml for both I and II. The assay is applicable to clinical pharmacokinetic studies. In one cancer patient who received both an oral and an intravenous dose of 10 mg of I the bioavailability was 82% and the clearance 20.8 ml/min.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / blood*
  • Antineoplastic Agents / metabolism
  • Biological Availability
  • Chromatography, High Pressure Liquid / methods*
  • Chromatography, High Pressure Liquid / statistics & numerical data
  • Humans
  • Metabolic Clearance Rate
  • Neoplasms / blood
  • Neoplasms / drug therapy
  • Podophyllotoxin / analogs & derivatives*
  • Podophyllotoxin / blood
  • Podophyllotoxin / metabolism
  • Quality Control
  • Sensitivity and Specificity

Substances

  • Antineoplastic Agents
  • NK 611
  • Podophyllotoxin